Beta-amyloid expression, release and extracellular deposition in aged rat brain slices (Q40181446)

18 September 2017

Beta-amyloid expression, release and extracellular deposition in aged rat brain slices (English)

1 reference

18 September 2017

Marksteiner J

1

1 reference

PubMed ID

17712316

18 September 2017

Humpel C

series ordinal

2

1 reference

PubMed ID

17712316

18 September 2017

language of work or name

English

0 references

publication date

21 August 2007

1 reference

18 September 2017

1 reference

18 September 2017

13

1 reference

18 September 2017

10

1 reference

18 September 2017

939-952

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4002072

18 September 2017

0 references

cites work

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Mechanisms of neuronal degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Cholinergic strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Chromogranin peptides in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Regulation of brain-derived neurotrophic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Nerve growth factor does not influence the expression of beta amyloid precursor protein mRNA in rat brain: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Organotypic slice cultures: a technique has come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

A simple method for organotypic cultures of nervous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Organotypic slice cultures from transgenic mice as disease model systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4(695) mRNA is predominantly produced in rat and human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

BetaA amyloid peptide (25-35) induced APP expression in cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Cerebrovascular damage as a cause for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

A dynamic relationship between intracellular and extracellular pools of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

To think or not to think: synaptic activity and Abeta release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Eight-residue Abeta peptides inhibit the aggregation and enzymatic activity of Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

APOE, vascular pathology, and the AD brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Apolipoprotein E and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Production of the Alzheimer's beta-amyloid peptide by C6 glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002072

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4002072

1 reference

18 September 2017

1 reference

PubMed ID

17712316